female urinary incontinence Flashcards

1
Q

urinary incontinence (UI)

A

any involuntary leakage of urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

stress urinary incontinence (SUI)

A

involuntary leakage on effort or exertion, on sneezing or coughing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

urge urinary incontinence (UUI)

A

involuntary leakage accompanied by or immediately preceded by urgency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mixed urinary incontinence (MUI)

A

involuntary leakage accompanied by or immediately preceded by urgency and on effort on exertion, or sneezing/coughing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

impact of UI

A

impair QI
reduce social relationships and activities
impair emotional and psychological wellbeing
impair sexual relationships
embarrassment and diminished self esteem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

UI risk factors

A
age 
parity 
menopause 
smoking 
inc abdominal pressure
pelvic floor trauma 
denervation 
connective tissue disease
surgery 

main risk factor for SUI: pregnancy and childbirth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

patient assessment: history

A

age, parity, mode of deliveries, weight heaviest babies, smoking HRT

medical conditions: DM, anti-htn drugs, glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

patient symptoms

A

irritation symptoms:

  • urgency
  • inc daytime and nighttime frequency
  • dysuria
  • haematuria

incontinence symptoms:

  • stress UI
  • urgency UI
  • coital incontinence
  • severity - how many pads a day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 days urinary diary

A
fluid intake: quantity and quality 
urine output 
nocturia 
avg voided volume 
also urine dipstick
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

examination of woman with bladder/pelvic floor problems

A
general 
abdominal 
neurological 
gynaecological 
pelvic floor assessment
prolapse
stress incontinence
uro-genital atrophy changes
pelvic mass
pelvic floor tone, strength, awareness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

investigations

A

urinalysis: multistix +/- MSSU
post-voiding residual volume assessment (usually by bladder scanning) if symptoms voiding difficulty
urodynamics if surgical Rx contemplated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

management: lifestyle changes

A

stop smoking
lose weight
eat more healthily to avoid constipation
stop drinking alcohol and caffeine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

management: pelvic floor muscle training

A

reinforcement of cortical awareness of muscle groups
hypertrophy of existing muscle fibres
general increase in muscle tone and strenth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pharmacological management

A

yentreve (TM)
(duloxetine)

first and only drug liscened for Rx moderate to severe stress urinary incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

who should receive duloxetine

A

primary care: if PFMT failed or would be enhanced by it

secondary care:

  • do not wish surgery
  • not fit for surgery
  • after failed surgery
  • patient’s family not complete
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

surgical management

A

retro-pubic RVT (1st choice)

colposuspension

17
Q

overactive bladder syndrome

A

symptom complex, usually relate to urodynamically demonstable detrusor overactivity

defining symptoms: urgency (with/without urge incontinence), usually with frequency and nocturia

18
Q

causes of overactive bladder syndrome

A

detrusor activity (mostly)

urethrovesical dysfunction

19
Q

risk factors for urge incontinence

A

advanced age
diabetes
UTIs
smoking

20
Q

OAB conservative management

A

lifestyle interventions

  • normalise fluid intake
  • reduce caffeine, fizzy drinks, chocolate
  • stop smoking
  • weight loss

bladder training programme

  • timed voiding with gradually increasing intervals - continence nurse
  • timed bladder emptying programme
21
Q

OAB pharmacological treatment

A

anti-muscarinic: oral or transdermal

tri-cyclic antidepressants (imipramine)

botox
neuromodulation